Just in time for the holidays —exciting news! Our latest validation study is out in the Journal of Translational Medicine: "Novel color vision assessment tool: AIM color detection and discrimination" by Jingyi He, @janskerswetat.bsky.social , & Peter Bex.

We received the news that a paper on visual motion & form coherence processing in cerebral visual impairment using our FInD technology, published in Developmental Medicine & Child Neurology, is among the top 10 most-cited papers of 2023 by Mac Keith Press! #visionresearch #CVI

We received the news that a paper on visual motion & form coherence processing in cerebral visual impairment using our FInD technology, published in Developmental Medicine & Child Neurology, is among the top 10 most-cited papers of 2023 by Mac Keith Press! #visionresearch #CVI

Join us at the ARVO Annual Meeting, the premier gathering for eye & vision scientists globally, held May 4-8, 2025, in Salt Lake City, Utah. We will present 3 different projects, stay tuned for more information in the coming days. #ARVO2025 #VisionScience @arvoinfo.bsky.social perzeption.vision/Blog

Important Team Update: Orion Wilmerding, software architect and previous founder in the medical device sector, has joined the PerZeption team as Chief Technology Officer. #visionscience #medicaldevice www.prnewswire.com/news-release...

Our PerZeption app’s tablet-based CVD screening got a spotlight in JOSAA! AIM & FInD methods showed strong results for efficient, accurate testing. Read more about how we’re advancing vision diagnostics in our latest blog perzeption.vision/Blog #VisionScience #ColorVision

One in four people—2.2 billion—face vision loss. Our mission is to prevent this with cutting-edge vision assessment software for clinicians. We’ve validated our app, scaled our tech, expanded our team, and redesigned our webpage. Our new app is ready—more updates soon. perzeption.vision/Blog